Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Depreciation and Depletion (2024 - 2025)

Historic Depreciation and Depletion for Medifast (MED) over the last 2 years, with Q4 2025 value amounting to $2.6 million.

  • Medifast's Depreciation and Depletion rose 1304.35% to $2.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.5 million, marking a year-over-year decrease of 3965.52%. This contributed to the annual value of $10.5 million for FY2025, which is 3965.52% down from last year.
  • Per Medifast's latest filing, its Depreciation and Depletion stood at $2.6 million for Q4 2025, which was up 1304.35% from $2.5 million recorded in Q3 2025.
  • Medifast's 5-year Depreciation and Depletion high stood at $10.5 million for Q2 2024, and its period low was $2.3 million during Q1 2024.